Video Latest - ecancer

Editor's Choice for July 2016

Prof Gordon McVie - Editor in Chief, ecancer

25 Jul 2016

The steady progress of targeted therapies

Dr Anton Berns - Netherlands Cancer Institute, Amsterdam, Netherlands

20 Jul 2016

Prof Michael Seckl: Why attend Future Horizons in Lung Cancer?

Prof Michael Seckl - Imperial College London, London

17 Jul 2016

Polycomb repressors and epigenetic therapy

Dr Maarten van Lohuizen - Netherlands Cancer Institute, Netherlands, UK

15 Jul 2016

The changing process of drug discovery and design

Dr Ian Waddell - Cancer Research UK Manchester Institute, Manchester, UK

14 Jul 2016

Mouse models of lung cancer

Dr Anton Berns - Netherlands Cancer Institute, Amsterdam, Netherlands

13 Jul 2016

'Rewiring' tumour susceptibility

Dr Michael Yaffe - MIT, Cambridge, USA

13 Jul 2016

New targets in personalised therapy for patients with lung cancer

Prof Bruce Johnson - Dana-Farber Cancer Institute, Bethesda, USA

1 Jul 2016

Implementing strategies to prevent cancer

Dr Graham Colditz - Washington University in St. Louis, St. Louis, USA

30 Jun 2016

Halving cancer mortality

Prof Richard Peto - University of Oxford, Oxford, England

30 Jun 2016

Editor's Choice for June 2016

Prof Gordon McVie - ecancer Editor in Chief

29 Jun 2016

Editor's ASCO 2016 Roundup

Prof Gordon McVie - ecancer Editor in Chief

16 Jun 2016

Video